Related Experiment Video
Updated: Aug 24, 2026

A Mouse Model of Retinal Ischemia-Reperfusion Injury Through Elevation of Intraocular Pressure
Published on: July 14, 2016
Ocular hemorrhage possibly the result of HMG-CoA reductase inhibitors
1Casey Eye Institute, Oregon Health & Science University, Portland, OR 97201, USA. eyedrug@ohsu.edu
Abstract:
This retrospective case series describes the association between ocular hemorrhage and 3-hydroxy-3-methylglutaryl conenzyme A (HMG-CoA) reductase inhibitors (statins). The clinical characteristics of 95 case reports submitted to the World Health Organization (WHO), the Food and Drug Administration, and the National Registry of Drug-Induced Ocular Side Effects are summarized with classification of this ocular side effect according to WHO criteria. The average time to onset of ocular hemorrhage was 300 days with 11 positive dechallenge reports and 2 positive rechallenge cases. Some patients also received medications known to increase bleeding times. From the collected data, ocular hemorrhage is "possibly" due to statin therapy.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy
Glaucoma: Overview
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hemorrhagic Stroke l: Introduction
Photoreceptors and Visual Pathways